Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors*

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Biological Chemistry

• Publication date

  2011-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M110.213231PMID 21628462PMCID PMC3138267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WISP-1/CCN4 Regulates Osteogenesis by Enhancing BMP-2 Activity

  2010cited by this paper
• Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier

  2010cited by this paper
• Cyr61/CCN1 Displays High-Affinity Binding to the Somatomedin B 1–44 Domain of Vitronectin

  2010cited by this paper
• Alternative splicing of CCN mRNAs …. it has been upon us

  2009cited by this paper
• Functional Roles of Human Kallikrein-related Peptidases*

  2009cited by this paper
• Functions and mechanisms of action of CCN matricellular proteins.

  2009cited by this paper
• Normal growth and development in mice over-expressing the CCN family member WISP3

  2009cited by this paper
• N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.

  2009cited by this paper
• Proteins on the catwalk: modelling the structural domains of the CCN family of proteins

  2009cited by this paper
• Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids

  2008cited by this paper
• Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7

  2008cited by this paper
• Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions

  2008cited by this paper
• Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.

  2008cited by this paper
• Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration

  2008cited by this paper
• A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology

  2008cited by this paper
• Functions of KLK4 and MMP-20 in dental enamel formation

  2008cited by this paper
• Kallikrein-related peptidases

  2008cited by this paper
• The CCN family of proteins: structure–function relationships

  2008cited by this paper
• CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes.

  2008cited by this paper
• Enzymatic properties of human kallikrein-related peptidase 12 (KLK12)

  2007cited by this paper
• Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin.

  2007cited by this paper
• Nephroblastoma Overexpressed (Nov) Is a Novel Bone Morphogenetic Protein Antagonist

  2007cited by this paper
• Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3.

  2007cited by this paper
• Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E‐cadherin

  2007cited by this paper
• Defining the extended substrate specificity of kallikrein 1-related peptidases

  2007cited by this paper
• Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung Cancer

  2007cited by this paper
• Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.

  2007cited by this paper
• CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways.

  2007cited by this paper
• Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.

  2007cited by this paper
• New insights into the functional mechanisms and clinical applications of the kallikrein‐related peptidase family

  2007cited by this paper
• Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulation

  2007cited by this paper
• Distribution of 15 human kallikreins in tissues and biological fluids.

  2007cited by this paper
• Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase‐9 is not

  2007cited by this paper
• Identification of Candidate Angiogenic Inhibitors Processed by Matrix Metalloproteinase 2 (MMP-2) in Cell-Based Proteomic Screens: Disruption of Vascular Endothelial Growth Factor (VEGF)/Heparin Affin Regulatory Peptide (Pleiotrophin) and VEGF/Connective Tissue Growth Factor Angiogenic Inhibitory Co

  2007cited by this paper
• Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.

  2007cited by this paper
• Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor.

  2006cited by this paper
• Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)

  2006cited by this paper
• CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1.

  2006cited by this paper
• The C-terminal peptide of connective tissue growth factor blocks the full molecule binding to tubular epithelial cell.

  2006cited by this paper
• CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin α5β1

  2006cited by this paper
• A survey of alternative transcripts of human tissue kallikrein genes.

  2005cited by this paper
• The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.

  2005cited by this paper
• N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma.

  2005cited by this paper
• KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.

  2005cited by this paper
• Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7.

  2004cited by this paper
• Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy.

  2004cited by this paper
• The emerging roles of human tissue kallikreins in cancer

  2004cited by this paper
• Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero.

  2003cited by this paper
• Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF‐induced angiogenesis

  2002cited by this paper
• Matrix Metalloproteinases Cleave Connective Tissue Growth Factor and Reactivate Angiogenic Activity of Vascular Endothelial Growth Factor 165*

  2002cited by this paper
• Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells*

  2002cited by this paper
• Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

  2002cited by this paper
• Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β

  2002cited by this paper
• Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.

  2002cited by this paper
• Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer*

  2001cited by this paper
• The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated

  2001cited by this paper
• KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.

  2000cited by this paper
• The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling.

  1999cited by this paper
• Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings.

  1998cited by this paper
• Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells

  1998cited by this paper
• Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells.

  1998cited by this paper
• Purification and Characterization of Novel Heparin-binding Growth Factors in Uterine Secretory Fluids

  1997cited by this paper
• Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*)

  1996cited by this paper
• Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion

  1996cited by this paper
• The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*)

  1996cited by this paper
• Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.

  1993cited by this paper
• Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors.

  1993cited by this paper

• CCN1: A Dermo‐Epidermal Crosstalk Mediator and Regulatory Protein in Cutaneous Homeostasis

  2025cites this paper
• KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation

  2024cites this paper
• Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancer

  2024cites this paper
• An overview of CCN4 (WISP1) role in human diseases

  2024cites this paper
• Serum levels of the N-terminal fragment of connective tissue growth factor is a novel biomarker for chronic pancreatitis

  2024cites this paper
• Remodeling of the extracellular matrix by serine proteases as a prerequisite for cancer initiation and progression.

  2024cites this paper
• Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer

  2023cites this paper
• Remodelling of the tumour microenvironment by the kallikrein-related peptidases

  2022cites this paper
• Fibroblast Growth Factors and Cellular Communication Network Factors: Intimate Interplay by the Founding Members in Cartilage

  2022cites this paper
• SCO-spondin, a giant matricellular protein that regulates cerebrospinal fluid activity

  2021cites this paper
• Identification of Novel Anticancer Agent by in silico Methods for Inhibition of KLK-12 Protein

  2021cites this paper
• Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor

  2021cites this paper
• The CCN2/CTGF interactome: an approach to understanding the versatility of CCN2/CTGF molecular activities

  2021cites this paper
• Kallikrein‐related peptidase 5 contributes to the remodeling and repair of bronchial epithelium

  2021cites this paper
• Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients

  2020cites this paper
• Extracellular proteolysis in glioblastoma progression and therapeutics.

  2020cites this paper
• Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms

  2020influential citation
• Eyeing the Extracellular Matrix in Vascular Development and Microvascular Diseases and Bridging the Divide between Vascular Mechanics and Function

  2020cites this paper
• Kallikrein 12 Regulates Innate Resistance of Murine Macrophages against Mycobacterium bovis Infection by Modulating Autophagy and Apoptosis

  2019cites this paper
• Caught between a “Rho” and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?

  2019cites this paper
• Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

  2019cites this paper
• Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer

  2018cites this paper
• Kallikrein-related peptidases in lung diseases

  2018cites this paper
• Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix

  2018cites this paper
• Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors.

  2018cites this paper
• Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation

  2018cites this paper
• KLK12 (kallikrein-related peptidase 12)

  2018cites this paper
• Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy

  2017cites this paper
• PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastoma

  2017cites this paper
• Biochemical and functional characterization of the human tissue kallikrein 9.

  2017cites this paper
• INVESTIGATION OF THE PUTATIVE BIOLOGICAL SUBSTRATES FOR HUMAN KALLIKREIN-RELATED PEPTIDASE 7

  2017cites this paper
• Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).

  2017cites this paper
• The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.

  2016cites this paper
• Matrix reloaded: CCN, tenascin and SIBLING group of matricellular proteins in orchestrating cancer hallmark capabilities.

  2016cites this paper
• Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy

  2016cites this paper
• Kallikreins - The melting pot of activity and function.

  2016cites this paper
• Kallikrein-related peptidases (KLKs) and the hallmarks of cancer

  2016cites this paper
• Regulating the regulators of angiogenesis by CCN1 and taking it up a Notch

  2016cites this paper
• The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling

  2015cites this paper
• Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics*

  2015cites this paper
• New functional aspects of CCN2 revealed by trans-omic approaches

  2015cites this paper
• Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions.

  2015cites this paper
• CCN1 (Cyr61) Is Overexpressed in Human Osteoarthritic Cartilage and Inhibits ADAMTS‐4 (Aggrecanase 1) Activity

  2015cites this paper
• The role of CTGF in diabetic retinopathy.

  2015cites this paper
• CCN1 secretion and cleavage regulate the lung epithelial cell functions after cigarette smoke.

  2014cites this paper
• Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.

  2014cites this paper
• Angiogenesis stimulated by human kallikrein‐related peptidase 12 acting via a platelet‐derived growth factor B‐dependent paracrine pathway

  2014cites this paper
• Putative kallikrein substrates and their (patho)biological functions

  2014cites this paper
• Proteomic and other analyses to determine the functional consequences of deregulated kallikrein‐related peptidase (KLK) expression in prostate and ovarian cancer

  2014cites this paper
• Degradome Products of the Matricellular Protein CCN1 as Modulators of Pathological Angiogenesis in the Retina*

  2013cites this paper
• Degradome Products of the Matricellular Protein CCN1 as Modulators of Pathological Angiogenesis in the Retina*

  2013cites this paper
• An exploration of pathways involved in lung carcinoid progression using gene expression profiling.

  2013cites this paper
• The CCN family acting throughout the body: recent research developments

  2013cites this paper
• The human tissue kallikrein and kallikrein-related peptidase family

  2013cites this paper
• Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor

  2013cites this paper
• Regulation of corneal scar formation by transforming growth factor beta and connective tissue growth factor: Roles of proteolytic processing and development of a gene silencing technique

  2012cites this paper
• Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance

  2012cites this paper
• CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis

  2012cites this paper
• Proteolytic processing of connective tissue growth factor in normal ocular tissues and during corneal wound healing.

  2012cites this paper
• Roles for CCN2 in normal physiological processes

  2011cites this paper
• Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets

  2011cites this paper